ALBUTROPIN Trademark

Trademark Overview

On Thursday, January 17, 2013, a trademark application was filed for ALBUTROPIN with the United States Patent and Trademark Office. The USPTO has given the ALBUTROPIN trademark a serial number of 85826006. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2016. This trademark is owned by Human Genome Sciences, Inc.. The ALBUTROPIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency
albutropin

General Information

Serial Number85826006
Word MarkALBUTROPIN
Filing DateThursday, January 17, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 23, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressBRENTFORD MIDDLESEX TW8 9GS
GB
Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 5, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 30, 2016EXTENSION 5 GRANTED
Monday, January 25, 2016EXTENSION 5 FILED
Monday, January 25, 2016TEAS EXTENSION RECEIVED
Thursday, July 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 22, 2015EXTENSION 4 GRANTED
Monday, July 13, 2015EXTENSION 4 FILED
Monday, July 13, 2015TEAS EXTENSION RECEIVED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 10, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 9, 2015EXTENSION 3 GRANTED
Tuesday, January 27, 2015EXTENSION 3 FILED
Tuesday, January 27, 2015TEAS EXTENSION RECEIVED
Friday, July 25, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 24, 2014EXTENSION 2 GRANTED
Friday, July 18, 2014EXTENSION 2 FILED
Friday, July 18, 2014TEAS EXTENSION RECEIVED
Wednesday, May 28, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, March 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 6, 2014EXTENSION 1 GRANTED
Tuesday, January 28, 2014EXTENSION 1 FILED
Monday, February 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 28, 2014TEAS EXTENSION RECEIVED
Tuesday, July 30, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 4, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 15, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 30, 2013ASSIGNED TO EXAMINER
Wednesday, January 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 21, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

albutropin growth hormone deficiency treatment protein preparations namely fusion pharmaceutical